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REVIEW
The role of prohormones, ‘classic’ and ‘designer’ steroids, clenbuterol, peptide hormones and newer molecules causing concern in dietary 
supplements is discussed. Apart from their potential adverse effects on athletes’ health, their non-achievement of increased strength and 
muscle size, trace quantities present in contaminated dietary supplements can lead to failed doping tests. The methodologies used for the 
identification and determination of prohibited substances in very low concentrations, mainly liquid chromatography and mass spectrometry, 
are also addressed. Of concern is the anticipation that the number of dietary supplements containing (not yet) prohibited designer steroids 
and other performance-enhancing newer chemical entities will increase. Athletes, coaches and sports doctors should therefore be provided 
with information regarding dietary supplements and be advised to minimise risks for non-intentional ingestion of forbidden substances by 
using safe products listed on databases, such as those obtainable in The Netherlands and Germany.
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In Part 1[1] the focus was on the 
presence of stimulants in dietary 
supplements, while the current 
article deals with ‘classic’ and 
‘designer’ steroids, clenbuterol, 
peptide hormones and newer molecules that 
cause concern in sports nutrition due to their 
accidental intake as contaminants.
Prohormones
It has been shown in a previous study that 
~15% of dietary supplements comprising 
mainly vitamins, minerals, proteins and 
creatine contained undisclosed anabolic 
androgenic steroids.[2] These steroids were 
mainly prohormones, referring to androgenic 
precursors that are enzymatically activated in 
vivo to the anabolic steroid testosterone and 
its derivatives. In the aforementioned study, 
it was assumed that these prohormones 
were probably the result of contamination 
before or during manufacturing processes. 
Nevertheless, the quantities of prohormone 
detected in these supplements could 
have resulted in infringements of doping 
regulations. Prohormones are viewed by 
many consumers as natural compounds 
to promote strength and muscle mass, 
change body composition and improve 
general feelings of wellness with fewer 
adverse effects than testosterone itself 
or other synthetic androgenic steroids.[3] 
Furthermore, prohormones are perceived and 
commercially promoted as legal alternatives 
to testosterone, with comparable anabolic 
effects. However, prohormones are listed as 
prohibited substances on the World Anti-
Doping Agency (WADA) list and are illegal 
to sell or import in many countries.
Cholesterol is metabolised by multiple enzyme 
systems into testosterone via a number of 
androgenic intermediates (prohormones), 
including dihydroepiandrosterone (DHEA) 
(Fig. 1). The biosynthetic pathway via DHEA 
leads to the production of androstenedione 
(DIONE) and androstenediol (DIOL). These 
intermediates can also be converted to the 
oestrogens, which may cause gynaecomastia 
and hepatic dysfunction. To counteract 
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Fig. 1. Outline of major pathways in the biosynthesis of steroid hormones.
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these adverse effects, some athletes use 
prohormones out of the competition season 
in cycles lasting 4 - 12 weeks, either alone 
or in a stacking manner, i.e. taking multiple 
compounds with different oestrogenic 
potential simultaneously. Alternatively, 
users may follow a pyramid mode, taking 
the highest doses in midcycle. Additionally, 
selective oestrogen receptor modulators or 
aromatase inhibitors (Fig. 1) may be taken to 
attenuate oestrogenic effects, and androgenic 
herbal products taken to diminish the low 
period between cycles. [3,4] However, two well-
conducted clinical studies have not shown 
DHEA, DIONE or DIOL to produce any 
advantageous anabolic or ergogenic effects 
at all, but have confirmed the risk of adverse 
effects. In particular, in one of the studies, 
LDL-cholesterol/HDL-cholesterol ratios were 
increased by 11%, significantly elevating the 
risk for cardiovascular disease and reducing 
luteinising hormone levels, which may 
decrease testicular and adrenal testosterone 
production.[3] Other prohormones, e.g. 
those of the much-used/abused anabolic 
steroid 19-nortestosterone (nandrolone), 
have also appeared on the market.[5] One of 
these prohormones, norandrostendione, 
administered as a single dose, has been 
shown to lead to detectable urinary quantities 
of the main metabolite (19-norandrosterone) 
of the parent steroid nandrolone for a period 
>10 days.[5]
Classic anabolic steroids
Steroid structures have perhydrocyclopenta-
nophenanthrene nuclei comprising four 
rings (A, B, C and D), as represented by the 
structure of testosterone (Fig. 2). Loci where 
modifications occur as well as examples 
of typical reactions, resulting in structural 
modifications to the steroid nucleus, are 
also shown. Furthermore, steroids can be 
classi fied into six groups according to the 
number of carbon atoms, i.e. gonanes (C17), 
estranes (C18) (e.g. oestradiol and oestrone), 
andro stanes (C19) (e.g. testosterone and 
andro stenedione), pregnanes (C21) (e.g. 
pro gesterone and cortisol), cholanes (C24) 
(e.g. cholic acid and desoxycholic acid) and 
chole stanes (C27) (e.g. cholesterol). With 
the exception of the cholanes, steroids 
are precursors or natural hormones that, 
depending on their in vivo functions, can 
be divided into oestrogens, androgens, 
glucocorticoids and mineralocorticoids. The 
steroid category of compounds includes the 
classic anabolic steroids, e.g. metandienone, 
stanozol, boldenone, oxandrolone, dehydro -
chloromethyl-testosterone, etc., which have 
been found in high amounts (>1 mg/g) in 
certain dietary supplements and vitamin 
preparations that are freely available on the 
market. These steroid ingredients were either 
listed on package labels under some other 
chemical/non-approved name or not disclosed 
at all. Concentrations of these steroids in the 
supplements were of such orders that even 
within the limits of recommended supplement 
intake, supratherapeutic doses of these 
substances would be ingested. Many athletes 
and other individuals in the population at large, 
including women, adolescents and children, 
regularly consume dietary supplements in 
quantities beyond the safe daily recommended 
doses, and therefore adverse effects in these 
groups of users could be severe. In men, 
acne, testicular atrophy, prostate enlargement, 
decreased spermatogenesis, infertility, impo-
tence and changes in libido may occur.[6] 
Furthermore, gynaecomastia, which may 
require surgical intervention, can also occur; 
some male users of steroids concurrently use 
tamoxifen or other agents to prevent or treat 
this condition. In women using steroids, 
acne, potentially irreversible masculinisation, 
clitoris enlargement, menstrual irregularities 
and changes in libido may result. In both sexes, 
psychiatric effects, e.g. aggression (‘roid’ rage), 
psychoses, manic episodes, panic disorders, 
depression, etc. have been documented. 
Long-term steroid use has also been associ-
ated with dependency and a withdrawal 
syndrome associated with suicidal thoughts, 
an increased incidence of tumours and 
premature mortality.[6] Of particular concern 
are the effects of steroids on cholesterol and 
lipid metabolism, hypercalcaemia, electrolyte 
and fluid disturbances, hypertension and 
thrombotic events, e.g. emboli, myocardial 
infarction and cerebrovascular accidents, 
the latter two conditions possibly resulting 
from an increase in platelet aggregation and 
erythrogenesis. In adolescents and children, 
virilisation and premature closure of the 
epiphyseal plates, which may result in stunted 
growth, have been described. Most of the 
classic anabolic steroids are methylated in the 
17-position of the D-ring of the perhydro-
cyclopentanophenanthrene nucleus (Fig. 2), a 
molecular feature that is associated with high 
hepatoxicity and carcinogenicity.[5]
While the commercial sources of these 
steroids on the world market are not always 
known, it appears as if many of them are 
sourced from Chinese bulk manufacturers 
and are intentionally incorporated into dietary 
supplements by unscrupulous companies.[5]
Designer steroids
These steroid molecules were synthesised some 
5 decades ago and evaluated in preclinical 
studies for their anabolic and androgenic 
effects.[7] They are not listed as components 
of any currently available pharmaceuticals 
for clinical use, are not on the WADA list of 
prohibited substances and are manufactured 
exclusively for the dietary supplement black 
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Fig. 2. Some structural modifications of the steroid nucleus, using the testosterone molecule as 
an example.
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market. Examples of such agents, to name but a few, are prostanozol, 
methasterone and andostatrienedione, and to date more than 40 such 
designer steroid molecules have been detected in laboratories.[7] Little 
is known regarding their pharmacological actions and safety profiles in 
humans. They are either listed under some other chemical/non-approved 
name or are not disclosed at all on dietary supplement labels. Should 
metabolites of these designer steroids be detected in an athlete’s urine, 
doping infringement charges would probably ensue.
Clenbuterol
Many athletes who claim that they suffer from asthma or exercise-
induced asthma use metered-dose inhaled β2-agonists for alleviating 
their symptoms of bronchoconstriction. While the inhalational β2-
agonists such as terbutaline, albuterol and salmeterol are permitted 
for use by athletes by the WADA, oral and injectable forms of these 
pharmaceuticals are not. However, some of these β2-agonists, e.g. 
clenbuterol, are considered anabolic substances by some sports-
governing agencies. Hitherto, two cases have been described in which 
dietary supplements contained therapeutic and supratherapeutic 
doses of 30 µg/tablet and 2 mg/capsule of clenbuterol, respectively.[8] 
In the supratherapeutic preparation, which contained 100 times the 
therapeutic dose of clenbuterol, the presence of this β2-agonist was not 
disclosed on the package label.
Peptide hormones
Over-the-counter dietary supplements are frequently promoted by 
manufacturers as being able to increase human growth hormone 
levels in the body. However, a review has shown that while human 
growth hormone does increase lean body mass, it has no beneficial 
effect on strength or exercise capacity in trained athletes.[9] However, 
use of human growth hormones has been associated with higher 
rates of soft-tissue oedema, arthralgias and carpal tunnel syndrome. 
Furthermore, dietary supplements advertised as having anabolic, fat-
reducing and anticatabolic properties, and containing the prohibited 
growth hormone-releasing peptide-2 (GHRP-2), were detected a few 
years ago. The presence of such substances may lead to inadvertent 
doping infringements. While GHRP-2 itself is not specifically barred 
by the WADA for use by athletes, it is a releasing factor that belongs 
to a prohibited substance group on their list.[7]
Other newer molecules
A selective androgen receptor modulator and agonists of the peroxi some 
proliferator-activated receptor δ, which produce anabolic effects and 
enhance endurance, respectively, have been found on the black market.[7]
It has also come to the attention of the WADA that another sub-
stance for increasing endurance, GW501516, has been available for 
some time on the black market, through the internet and elsewhere. 
Anti-doping authorities have already seen its use by athletes, as 
there have been a number of positive cases. This developmental drug 
has not been approved for clinical use anywhere in the world and 
has been withdrawn from further investigation by pharmaceutical 
companies due to its serious toxicity profile.[10]
Identification and determination of prohibited substances
While a wide variety of analytical techniques have been used in the past 
to detect prohibited drugs in biological fluids, rapid improvements 
in mass spectrometry (MS) have allowed accredited laboratories to 
develop specific and comprehensive screening methods that are able 
to detect amounts of drugs and/or their metabolites in quantities 
as low as 1 mg/L in urine.[4] Over many years, gas chromatography 
(GC) has proven itself in laboratories to be a useful technique for 
separating and identifying individual components in mixtures of 
chemical compounds on various chromatographic columns in terms 
of their retention characteristics (relative to an internal standard 
compound), as well as for quantifying them. A variety of detectors, 
e.g. flame ionisation detectors, thermal conductivity detectors and 
electron capture detectors have been used for this purpose. However, 
for the successful application of this technique, it is a prerequisite that 
for compounds to be separated, they are volatile, usually after the 
necessary derivatisation steps. Samples may also have to be hydrolysed 
to release steroid metabolites from their glucuronic acid conjugates, 
usually by means of the enzyme β2-glucuronidase, which may result 
in the generation of related steroidal compounds or incomplete 
deconjugation. For the purpose of volatilisation, the mixtures to 
be analysed are often trimethylsilylated (TMS) prior to injection 
onto GC columns. The more volatile TMS ethers of the individual 
components are then distributed between gaseous and solid phases, 
separated and detected. By feeding gaseous effluents from a GC into 
an MS, further improvement in identification and quantitation of 
compounds in mixtures can be expected. However, this technique of 
GC/MS is not so eminently suitable for routine clinical analysis, but 
has better applications as a screening tool of prohibited compounds in 
dietary supplements or urinary metabolites because of the high labour 
intensiveness, high cost and relatively poor sensitivity. The poor 
sensitivity is of relevance when samples are analysed for compounds 
which have low thermal stabilities, e.g. steroids such as trenbolone 
and gestrinone.[4] 
In recent years, another chromatographic tool, i.e. liquid chroma-
tography (LC) coupled to ultraviolet or diode-array detectors, 
has become increasingly important in drug-assaying laboratories. 
However, similar to GC, this method is not sensitive enough to detect 
trace levels of compounds and is not well suited for the identification 
of new substances with unknown chemical and physical properties. 
Coupled with MS, it provides specificity, precision and high 
sensitivity, allowing the detection of very low quantities of polar and 
non-polar compounds, a requirement being that the methodology 
be extensively validated. LC/MS has high throughput capabilities, 
requires small sample volumes, minimal sample preparation and 
thermal stability is usually not a factor. Furthermore, if required, a 
number of components can be identified and quantified in a single 
analysis within the dynamic calibration range of the instrumentation, 
which can span four orders of magnitude. Additionally, because of 
the absence of hydrolysis or derivatisation steps, LC/MS can be used 
to measure concentration ratios for steroids between conjugated and 
free forms, thereby lowering the risk of false positive or misleading 
outcomes.
The use of ultra-high performance LC has further improved 
chromatographic resolution, thereby lowering the possibility of 
missing potentially important co-eluting analytes, and critical 
pairs of isomers may be separated and detected. Coupled with high 
acquisition rate mass analysers such as triple quadrupole MS in 
tandem with LC/MS(/MS), exceptionally powerful techniques have 
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evolved in the detection of steroids with marginal GC properties, 
for example. [11- 13] Methodologies such as these have enabled the 
identification of characteristic product ions of common steroid 
structures and nuclei.[11] These powerful analytical tools provide a 
means of detecting a wide variety of unknown steroids based on 
common chemical structural properties, new metabolites, as well 
as new designer steroids (likely to be added to dietary supplements) 
made to circumvent anti-doping controls.
Conclusion
Dietary supplement use among athletes to enhance performance 
is proliferating as more individuals strive to obtain a chemical 
competitive edge. As a result, the concomitant use of dietary 
supplements containing performance-enhancing substances that fall 
in the categories outlined in the current review can also be expected 
to rise. This is despite ever-increasing, sophisticated analytical 
methodology techniques being used to assay dietary supplement 
and urine samples in doping laboratories. The reasons for this 
include: a variety of these chemical entities, many of them on the 
prohibited drug list of the WADA, are being produced commercially 
in factories around the world; aggressive marketing strategies are 
being employed by companies; and these supplements can be easily 
ordered, for example via the internet. It can also be anticipated that 
there will be an increase in the number of supplements containing 
designer steroids and other newer molecules. Chromatographic 
techniques combined with MS, leading to identification of molecular 
fragments and product ions, will assist in determining these 
substances. To prevent accidental doping, information regarding 
dietary supplements must be provided to athletes, coaches and sports 
doctors at all levels of competition. In South Africa, this situation 
is complicated by the fact that the system of Acts and Bills lacks 
specificity regarding nutritional supplements, including the listing of 
prohibited substances on package labels.[14,15] The risks of accidental 
doping via dietary supplement ingestion can be minimised by using 
safe products listed on databases, e.g. such as those available in The 
Netherlands and Germany.[5] Finally, athletes must be reminded that 
if they test positive for a prohibited substance not disclosed on the 
package label of a supplement, it would constitute a doping violation, 
with all the consequences thereof.
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